Skip to main content

Table 3 Comparison of parameters before and after treatment in each group

From: Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients

  Sevelamer (n = 23) Calcium Carbonate (n = 27)
BT AT P BT AT P
Ca (mg/dL) 9.37 ± 0.66 9.63 ± 0.80 0.038* 9.37 ± 0.73 10.17 ± 0.90 0.000*
P (mg/dL) 6.54 ± 0.91 5.07 ± 0.85 0.000* 7.22 ± 0.98 5.70 ± 1.01 0.000*
iPTH (pg/mL) 354.70 (332.70) 329.60 (319.80) 0.903 320.90 (371.8) 165.20 (405.60) 0.001*
ALK-P (IU/L) 82.17 ± 32.71 112.43 ± 43.21 0.004* 65.67 ± 23.70 64.41 ± 23.13 0.609
HsCRP (mg/L) 2.3 (5.8) 1.6 (3.1) 0.003* 3.10 (6.1) 1.9 (6.6) 0.866
Hct (%) 33.10 ± 3.87 32.80 ± 3.72 0.728 32.49 ± 3.11 32.49 ± 4.58 0.996
Albumin (g/L) 39.92 ± 3.13 39.96 ± 3.02 1.000 39.81 ± 2.86 40.78 ± 2.95 0.062
TG (mg/dL) 98.00 (86.00) 96.00 (103) 0.891 113.00 (127.00) 103.00 (65) 0.343
LDL-C (mg/dL) 108.96 ± 30.10 63.91 ± 20.55 0.000* 112.93 ± 33.46 105.19 ± 30.93 0.157
Fetuin-A (ug/mL) 210.61 (104.73) 153.85 (38.64) 0.003* 203.95 (107.87) 170.90 (58.02) 0.002*
  1. BT before treatment, AT after treatment
  2. Data are mean ± standard deviation or median (interquartile range, IQR)
  3. P < 0.05*